Production and characterization of improved adenovirus vectors with the E1, E2b, and E3 genes deleted

Journal of Virology

Volumn 72, Issue 2, 1998, Pages 926-933

  Amalfitano, Andrea ^a   Hauser, Michael A ^b   Hu, Huimin ^a   Serra, Delila ^a   Begy, Catherine R ^b   Chamberlain, Jeffrey S ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; ARTICLE; GENE ISOLATION; GENE THERAPY; NONHUMAN; PRIORITY JOURNAL; VIRUS GENE; VIRUS REPLICATION;

EID: 0031883829     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.2.926-933.1998     Document Type: Article

References (47)

1. Amalfitano, A., C. R. Begy, and J. S. Chamberlain. 1996. Improved adenovirus packaging cell lines to support the growth of replication-defective gene-delivery vectors. Proc. Natl. Acad. Sci. USA 93:3352-3356.
2. Amalfitano, A., and J. S. Chamberlain. 1997. Isolation and characterization of packaging cell lines that coexpress the adenovirus DNA polymerase and preterminal proteins: implications for gene therapy. Gene Ther. 4:258-263.
3. Armentano, D., J. Zahner, C. Sacks, C. C. Soukden, M. P. Smith, J. A. Stgeorge, S. C. Wadsworth, A. E. Smith, and R. J. Gregory. 1997. Effect of the E4 region on the persistence of transgene expression from adenovirus vectors. J. Virol. 71:2408-2416.
4. Askari, F. K., Y. Hitomi, M. Mao, and J. M. Wilson. 1996. Complete correction of hyperbilirubinemia in the Gunn rat model of Crigler-Najjar syndrome type 1 following transient in vivo adenovirus-mediated expression of human bilirubin UDP-glucuronosyltransferase. Gene Ther. 3:381-388.
5. Barr, D., J. Tubb, D. Ferguson, A. Scarla, A. Lieber, C. Wilson, J. Perkins, and M. A. Kay. 1995. Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther. 2:151-155.
6. Barr, E., J. Carroll, A. M. Kalynych, S. K. Tripathy, K. Kozarsky, J. M. Wilson, and J. M. Leiden. 1994. Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus. Gene Ther. 1:51-58.
7. Clemens, P. R., S. Kochanek, Y. Sunada, S. Chan, H. H. Chen, K. P. Campbell, and C. T. Caskey. 1996. In vivo muscle gene transfer of full-length dystrophin with an adenoviral vector that lacks all viral genes. Gene Ther. 3:965-972.
8. Cox, G. A., N. M. Cole, K. Matsumura, S. F. Phelps, S. D. Hauschka, K. P. Campbell, J. A. Faulkner, and J. S. Chamberlain. 1993. Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity. Nature 364:725-729.
9. Engelhardt, J. F., R. H. Simon, Y. Yang, M. Zepeda, S. Weber-Pendleton, B. Doranz, M. Grossman, and J. M. Wilson. 1993. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: biological efficacy study. Hum. Gene Ther. 4:759-769.
10. Gao, G. P., Y. P. Yang, and J. M. Wilson. 1996. Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy. J. Virol. 70:8934-8943.
11. Ghadge, G. D., R. P. Roos, U. J. Kang, R. Wollmann, P. S. Fishman, A. M. Kalynych, E. Barr, and J. M. Leiden. 1995. CNS gene delivery by retrograde transport of recombinant replication-defective adenoviruses. Gene Ther. 2:132-137.
12. Gilgenkrantz, H., D. Duboc, V. Juillard, D. Couton, A. Pavirani, J. G. Guillet, P. Briand, and A. Kahn. 1995. Transient expression of genes transferred in vivo into heart using first-generation adenoviral vectors - role of the immune response. Hum. Gene Ther. 6:1265-1274.
13. Hardy, S., M. Kitamura, T. Harris-Stansil, Y. M. Dai, and M. L. Phipps. 1997. Construction of adenovirus vectors through Cre-lox recombination. J. Virol. 71:1842-1849.
14. Hauser, M. A., A. Amalfitano, and J. S. Chamberlain. Unpublished data.
15. Heikkila, P., T. Parpala, O. Lukkarinen, M. Weber, and K. Tryggvason. 1996. Adenovirus-mediated gene transfer into kidney glomeruli using an ex vivo and in vivo kidney perfusion system - first steps towards gene therapy of Alport syndrome. Gene Ther. 3:21-27.
16. Horellou, P., E. Vigne, M. N. Castel, P. Barneoud, P. Colin, M. Perricaudet, P. Delaere, and J. Mallet. 1994. Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease. Neuroreport 6:49-53.
17. Ilan, Y., G. Droguett, N. R. Chowdhury, Y. A. Li, K. Sengupta, N. R. Thummala, A. Davidson, J. R. Chowdhury, and M. S. Horwitz. 1997. Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long-term gene expression. Proc. Natl. Acad. Sci. USA 94:2587-2592.
18. Jones, N., and T. Shenk. 1978. Isolation of deletion and substitution mutants of adenovirus type 5. Cell 13:181-188.
19. Kaplan, J. M., D. Armentano, T. E. Sparer, S. G. Wynn, P. A. Peterson, S. C. Wadsworth, K. K. Couture, S. E. Pennington, J. A. St. George, L. R. Gooding, and A. E. Smith. 1997. Characterization of factors involved in modulating persistence of transgene expression from recombinant adenovirus in the mouse lung. Hum. Gene Ther. 8:45-56.
20. Kay, M. A., A. X. Holterman, L. Meuse, A. Gown, H. D. Ochs, P. S. Linsley, and C. B. Wilson. 1995. Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration. Nat. Genet. 11:191-197.
21. Kochanek, S., P. R. Clemens, K. Mitani, H. H. Chen, S. Chan, and C. T. Caskey. 1996. A new adenoviral vector - replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase. Proc. Natl. Acad. Sci. USA 93:5731-5736.
22. Kumarsingh, R., and J. S. Chamberlain. 1996. Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells. Hum. Mol. Genet. 5:913-921.
23. Lieber, A., C. Y. He, I. Kirillova, and M. A. Kay. 1996. Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo. J. Virol. 70:8944-8960.
24. Lochmuller, H., B. J. Petrof, G. Pari, N. Larochelle, V. Dodelet, Q. Wang, C. Allen, S. Prescott, B. Massie, J. Nalbantoglu, and G. Karpati. 1996. Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice. Gene Ther. 3:706-716.
25. Mittereder, N., K. L. March, and B. C. Trapnell. 1996. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J. Virol. 70:7498-7509.
26. Nevins, J. R. 1981. Mechanism of activation of early viral transcription by the adenovirus E1a gene product. Cell 26:213-220.
27. Nevins, J. R., M. J. Imperiale, H. T. Kao, S. Strickland, and L. T. Feldman. 1984. Detection of an adenovirus E1a-like activity in mammalian cells. Curr. Top. Microbiol. Immunol. 113:15-19.
28. Niwa, M., S. D. Rose, and S. M. Berget. 1990. In vitro polyadenylation is stimulated by the presence of an upstream intron. Genes Dev. 4:1552-1559.
29. Ohashi, T., K. Watabe, K. Uehara, W. S. Sly, C. Vogler, and Y. Eto. 1997. Adenovirus-mediated gene transfer and expression of human beta-glucuronidase gene in the liver, spleen, and central nervous system in mucopolysaccharidosis type VII mice. Proc. Natl. Acad. Sci. USA 94:1287-1292.
30. Parks, R. J., L. Chen, M. Anton, U. Sankar, M. A. Rudnicki, and F. L. Graham. 1996. A helper-dependent adenovirus vector system - removal of helper virus by cre-mediated excision of the viral packaging signal. Proc. Natl. Acad. Sci. USA 93:13565-13570.
31. Ragot, T., N. Vincent, P. Chafey, E. Vigne, H. Gilgenkrantz, D. Couton, J. Cartaud, P. Briand, J. C. Kaplan, M. Perricaudet, et al. 1993. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature 361:647-650.
32. Sawchuk, S. J., G. P. Boivin, L. E. Duwel, W. Ball, F. Bove, B. Trapnell, and R. Hirsch. 1996. Anti-T cell receptor monoclonal antibody prolongs transgene expression following adenovirus-mediated in vivo gene transfer to mouse synovium. Hum. Gene Ther. 7:499-506.
33. Smith, T. A. G., B. D. White, J. M. Gardner, M. Kaleko, and A. McClelland. 1996. Transient immunosuppression permits successful repetitive intravenous administration of an adenovirus vector. Gene Ther. 3:496-502.
34. Stratford-Perricaudet, L. D., I. Makeh, M. Perricaudet, and P. Briand. 1992. Widespread long-term gene transfer to mouse skeletal muscles and heart. J. Clin. Invest. 90:626-630.
35. Tripathy, S. K., H. B. Black, E. Goldwasser, and J. M. Leiden. 1996. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat. Med. 2:545-550.
36. Vincent, N., T. Ragot, H. Gilgenkrantz, D. Couton, P. Chafey, A. Gregoire, P. Briand, J. C. Kaplan, A. Kahn, and M. Perricaudet. 1993. Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene. Nat. Genet. 5:130-134.
37. Wolff, J. A., J. J. Ludtke, G. Acsadi, P. Williams, and A. Jani. 1992. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum. Mol. Genet. 1:363-369.
38. Xiao, X. A., J. A. Li, and R. J. Samulski. 1996. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70:8098-8108.
39. Yang, Y., H. C. Ertl, and J. M. Wilson. 1994. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1:433-442.
40. Yang, Y., K. Greenough, and J. M. Wilson. 1996. Transient immune blockade prevents formation of neutralizing antibody to recombinant adenovirus and allows repeated gene transfer to mouse liver. Gene Ther. 3:412-420.
41. Yang, Y., Q. Li, H. C. Ertl, and J. M. Wilson. 1995. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69:2004-2015.
42. Yang, Y., F. A. Nunes, K. Berencsi, E. E. Furth, E. Gonczol, and J. M. Wilson. 1994. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91:4407-4411.
43. Yang, Y., F. A. Nunes, K. Berencsi, E. Gonczol, J. F. Engelhardt, and J. M. Wilson. 1994. Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nat. Genet. 7:362-369.
44. Yang, Y., Q. Su, and J. M. Wilson. 1996. Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs. J. Virol. 70:7209-7212.
45. Yang, Y., and J. M. Wilson. 1995. Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo. J. Immunol. 155:2564-2570.
46. Yang, Y. P., Z. Q. Xiang, H. C. J. Ertl, and J. M. Wilson. 1995. Upregulation of class I major histocompatibility complex antigens by interferon gamma is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo. Proc. Natl. Acad. Sci. USA 92:7257-7261.
47. Zhou, H. S., W. Oneal, N. Morral, and A. L. Beaudet. 1996. Development of a complementing cell line and a system for construction of adenovirus vectors with E1 and E2a deleted. J. Virol. 70:7030-7038.